HEARTWARE VENTRICULAR ASSIST SYSTEM
Medtronic · Decision date Apr 10, 2026
What did the FDA approve?
FDA records P100047/S223 as a supplement to PMA P100047, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Apr 10, 2026.
FDA approval order statement
Approval for a new HVAD battery charger, a new packaging configuration for the HVAD power cords, and labeling updates.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Apr 10, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P100047/S223
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic
- Product code
- DSQ
- Decision code
- APPR
- Decision date
- Apr 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
For the original device and its historical approval scope, see PMA P100047. Subsequent supplements may change the device or its indications.
FDA decision timeline
P100047 · Original PMA
HEARTWARE VENTRICULAR ASSIST SYSTEM
P100047/S223 received
Application receipt date recorded by FDA.
P100047/S236 · Related supplement
HeartWare HVAD System
P100047/S234 · Related supplement
HeartWare HVAD System
P100047/S235 · Related supplement
HeartWare HVAD System
P100047/S223 · FDA decision
Normal 180 Day Track
P100047/S238 · Related supplement
Heart Ware Ventricular Assist System (HVAD)
P100047/S239 · Related supplement
HeartWare Ventricular Assist System
P100047/S240 · Related supplement
HeartWare HVAD System
P100047/S241 · Related supplement
HeartWare HVAD System
Timeline entries are records held by MedtechLedger for P100047. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100047
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic | PMA approval | Nov 20, 2012 | FDA | |
HeartWare HVAD SystemP100047/S236 | Medtronic | PMA supplement | Feb 3, 2026 | FDA |
HeartWare HVAD SystemP100047/S234 | Medtronic | PMA supplement | Feb 18, 2026 | FDA |
HeartWare HVAD SystemP100047/S235 | Medtronic | PMA supplement | Apr 7, 2026 | FDA |
Heart Ware Ventricular Assist System (HVAD)P100047/S238 | Medtronic | PMA supplement | May 14, 2026 | FDA |
HeartWare Ventricular Assist SystemP100047/S239 | Medtronic | PMA supplement | Jul 28, 2026 | FDA |
HeartWare HVAD SystemP100047/S240 | Medtronic | PMA supplement | Aug 5, 2026 | FDA |
HeartWare HVAD SystemP100047/S241 | Medtronic | PMA supplement | Sep 23, 2026 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P100047/S223
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





